Report for: Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial

Title	Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial
Published in	Trials, December 2019
DOI	10.1186/s13063-019-3793-6
Pubmed ID	31829274
Authors	Maria Cristina Mondardini, Francesca Sperotto, Marco Daverio, Fabio Caramelli, Dario Gregori, Maria Francesca Caligiuri, Francesca Vitale, Maria Teresa Cecini, Marco Piastra, Aldo Mancino, Andrea Pettenazzo, Giorgio Conti, Angela Amigoni

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.

Type	Count	As %
Members of the public	4	67%
Practitioners (doctors, other healthcare professionals)	2	33%

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	76	100%

Readers by professional status	Count	As %
Researcher	10	13%
Student > Master	9	12%
Student > Doctoral Student	6	8%
Professor	5	7%
Student > Bachelor	5	7%
Other	17	22%
Unknown	24	32%

Readers by discipline	Count	As %
Medicine and Dentistry	26	34%
Nursing and Health Professions	12	16%
Social Sciences	3	4%
Engineering	2	3%
Immunology and Microbiology	1	1%
Other	8	11%
Unknown	24	32%

Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled…